Monthly Archives: February 2023

//February

MHRA Drug Safety Update February 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 7 February 2023) has been published and includes articles on: COVID-19 vaccines and medicines: updates for February 2023 Letters and medicine recalls sent to healthcare professionals in January 2023 To see the latest MHRA Drug Safety Updates in full, visit [...]

The post MHRA Drug Safety Update February 2023 appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update February 2023

Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free). MSN/2023/023 Tier 3 – high impact Date of issue 27th February 2023 Latanoprost (Monopost®) 50microgram/ml eye drops 0.2ml unit dose (preservative free) is out of stock until 17th March [...]

The post Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free) appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free)

Drug Tariff Watch – March 2023

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – March 2023 appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Drug Tariff Watch – March 2023

Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK)

Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK) Drug alert number: EL (23)A/05 Date issued: 27 February 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zestoretic 20mg/12.5mg Tablets, PL 43252/0035 SNOMED Code: 17403011000001101 Batch number Expiry date Pack size First distributed [...]

The post Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK) appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK)

Engaging with PSNC – please share your views

From April 1st PSNC will be renaming to Community Pharmacy England and putting in place a new communications and engagement strategy. We want to engage better and more regularly with pharmacy owners, to hear more of your views and ideas, and to enable to you to input more directly into the organisation. As we develop [...]

The post Engaging with PSNC – please share your views appeared first on PSNC Website.

By |February 24th, 2023|Lexpos News|Comments Off on Engaging with PSNC – please share your views